Medinotec Inc.
MDNC
$5.00
$0.000.00%
OTC PK
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 56.80% | 71.25% | 82.18% | 158.20% | 409.64% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 56.80% | 71.25% | 82.18% | 158.20% | 409.64% |
| Cost of Revenue | 26.36% | 54.66% | 66.23% | 212.66% | 814.58% |
| Gross Profit | 94.41% | 90.30% | 99.02% | 110.99% | 229.36% |
| SG&A Expenses | 44.07% | 0.32% | -14.32% | 41.54% | 129.03% |
| Depreciation & Amortization | -32.81% | -8.65% | 15.49% | 126.68% | 113.69% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.89% | 35.83% | 34.72% | 133.52% | 349.98% |
| Operating Income | 172.37% | 286.03% | 431.39% | 375.40% | 1,438.04% |
| Income Before Tax | 750.48% | 5,229.88% | 1,292.00% | 351.39% | 477.93% |
| Income Tax Expenses | 140.04% | 217.05% | 473.41% | 828.21% | 3,458.93% |
| Earnings from Continuing Operations | 10,364.38% | 743.32% | 633.58% | 237.71% | 80.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10,364.38% | 743.32% | 633.58% | 237.71% | 80.25% |
| EBIT | 172.37% | 286.03% | 431.39% | 375.40% | 1,438.04% |
| EBITDA | 154.73% | 253.50% | 374.13% | 318.31% | 778.12% |
| EPS Basic | 9,831.58% | 808.10% | 671.52% | 247.08% | 79.79% |
| Normalized Basic EPS | 203.31% | 350.58% | 556.03% | 1,175.86% | 1,124.53% |
| EPS Diluted | 9,831.58% | 808.10% | 671.52% | 247.08% | 79.79% |
| Normalized Diluted EPS | 203.31% | 350.58% | 556.03% | 1,175.86% | 1,124.53% |
| Average Basic Shares Outstanding | -2.15% | 9.27% | 9.27% | -4.22% | 1.14% |
| Average Diluted Shares Outstanding | -2.15% | 9.27% | 9.27% | -4.22% | 1.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |